Stay updated on Azacitidine and Pembrolizumab in MDS Clinical Trial
Sign up to get notified when there's something new on the Azacitidine and Pembrolizumab in MDS Clinical Trial page.

Latest updates to the Azacitidine and Pembrolizumab in MDS Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoChange DetectedA new page revision tag v3.6.3 was added, indicating a small update to the page version. This reflects a minor backend/content update rather than a substantive change to the study details.SummaryDifference0.1%

- Check16 days agoChange DetectedThe revision label on the page was updated from v3.6.0 to v3.6.2. This indicates a newer version without altering substantive content.SummaryDifference0.1%

- Check30 days agoChange DetectedUI labels and navigation elements have been updated on the study details page, including new sections such as 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study', and the 'Intervention/Treatment' heading with an updated revision footnote. Additionally, new metadata labels 'Last verified' and 'Last known status was' were added.SummaryDifference2%

- Check37 days agoChange DetectedRevision label updated from v3.5.4 to v3.5.5 on the page, indicating a minor version update. This change does not alter the study content or details.SummaryDifference0.1%

- Check59 days agoChange DetectedThe page now displays Revision: v3.5.4, indicating an updated version of the page content and replacing the previous Revision: v3.5.3.SummaryDifference0.1%

- Check73 days agoChange DetectedThe page shows a new revision version (v3.5.3) replacing the previous v3.5.2, indicating a small update to the page content or metadata. This change updates the revision history but does not alter substantive study information.SummaryDifference0.1%

Stay in the know with updates to Azacitidine and Pembrolizumab in MDS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Azacitidine and Pembrolizumab in MDS Clinical Trial page.